Merit Medical Systems (MMSI) Net Margin (2010 - 2026)

Merit Medical Systems has disclosed Net Margin across 17 years of filings, most recently posting 10.72% for Q1 2026.

• Net Margin for Q1 2026 came in at 10.72%, up 224.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.03% (up 22.0% YoY), and the FY2025 annual result was 8.48%, down 40.0% from the prior year.
• Net Margin came in at 10.72% for Q1 2026 at Merit Medical Systems, up from 9.65% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 10.72% in Q1 2026 to a low of 11.16% in Q4 2023.
• The 5-year median for Net Margin is 7.87% (2024), against an average of 6.43%.
• Across the five-year window, Net Margin slumped 1573 bps in 2023 and soared 1903 bps in 2024, its largest moves.
• Merit Medical Systems' Net Margin stood at 4.57% in 2022, then slumped by 344 bps to 11.16% in 2023, then jumped by 171 bps to 7.87% in 2024, then climbed by 23 bps to 9.65% in 2025, then grew by 11 bps to 10.72% in 2026.
• The last three Net Margin figures came in at 10.72% (Q1 2026), 9.65% (Q4 2025), and 7.22% (Q3 2025), per Business Quant data.